Adenosine receptors and asthma

Handbook of Experimental Pharmacology

Volumn 193, Issue , 2009, Pages 329-362

  Wilson, Constance N ^a   Nadeem, Ahmed ^b   Spina, Domenico ^c   Brown, Rachel ^c   Page, Clive P ^c   Mustafa, S Jamal ^a  

^a Endacea Inc   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adenosine; Adenosine receptors; Airway inflammation; Airway remodeling; Airway smooth muscle; Asthma; Bronchial hyperresponsiveness

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3 ISOBUTYL 8 PYRROLIDINOXANTHINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; [3 [2 (4 AMINOPHENYL)ETHYL] 8 BENZYL 7 [2 ETHYL (2 HYDROXYETHYL)AMINO]ETHYL] 1 PROPYL 3,7 DIHYDROPURINE 2,6 DIONE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A2B RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; ATROPINE; BUPIVACAINE; CORTICOSTEROID; CVT 6883; EPI 2010; GW 328267X; L 97 1; MRE 0094; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; QAF 805; SLV 320; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AIRWAY HYDRATION; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETIC FOOT; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HEART MUSCLE FIBROSIS; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RESPIRATORY TRACT DISEASE; REVIEW; WOUND; ANIMAL; METABOLISM; PHYSIOLOGY;

ADENOSINE; ANIMALS; ASTHMA; BRONCHOCONSTRICTION; HUMANS; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1;

EID: 70349327974     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-89615-9_11     Document Type: Review

References (189)

1. Abebe W, Mustafa SJ (1998) A1 adenosine receptor-mediated Ins(1,4,5)P3 generation in allergic rabbit airway smooth muscle. Am J Physiol 275:L990-L997
2. Ali S, Mustafa SJ,Metzger WJ (1992) Adenosine-induced bronchoconstriction in an allergic rabbit model: antagonism by theophylline aerosol. Agents Actions 37:165-167
3. Ali S, Mustafa SJ, Metzger WJ (1994a) Adenosine receptor-mediated bronchoconstriction and bronchial hyper-responsiveness in allergic rabbit model. Am J Physiol 266(Lung Cell Mol Physiol 10):L271-L277
4. Ali S, Mustafa SJ, Metzger WJ (1994b) Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. J Pharmacol Exp Ther 268:1328-1334
5. Allen-Gipson DS, Wong J, Spurzem JR, Sisson JH, Wyatt TA (2005) Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 290:L849-L855
6. An SS, Bai TR, Bates JH, Black JL, Brown RH, Brusasco V, Chitano P, Deng L, Dowell M, Eidelman DH, Fabry B, Fairbank NJ, Ford LE, Fredberg JJ, GerthofferWT, Gilbert SH, Gosens R, Gunst SJ, Halayko AJ, Ingram RH, Irvin CG, James AL, Janssen LJ, King GG, Knight DA, Lauzon AM, Lakser OJ, Ludwig MS, Lutchen KR, Maksym GN, Martin JG, Mauad T, McParland BE, Mijailovich SM, Mitchell HW, Mitchell RW, Mitzner W, Murphy TM, Pare PD, Pellegrino R, Sanderson MJ, Schellenberg RR, Seow CY, Silveira PS, Smith PG, Solway J, Stephens NL, Sterk PJ, Stewart AG, Tang DD, Tepper RS, Tran T, Wang L (2007) Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 29:834-860
7. Apasov S, Koshiba M, Redegeld F, Sitkovsky MV (1995) Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions. Immunol Rev 146:5-19
8. Avital A, Springer C, Bar-Yishay E, Godfrey S (1995) Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 50:511-516
9. Ball HA, Sandrasagra A, Tang L, ScottMV,Wild J, Nyce JW (2003) Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma. Am J Pharmacogenomics 3:97-106
10. Baraldi PG, Cacciari B, Romagnoli R, Merighi S, Varani K, Borea PA, Spalluto G (2000) A3 adenosine receptor ligands: history and perspectives. Med Res Rev 20:103-128
11. Barrett RJ (1996) Realizing the potential of adenosine-receptor-based therapeutics. Proc West Pharmacol Soc 39:61-66
12. Beier KC, Kallinich T, Hamelmann E (2007) T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease. Eur Respir J 30:383-390
13. Belda J, Casan P, Martínez C, Margarit G, Giner J, Homs R, Granel C, Sanchis J (2005) Bronchial plasma exudation after adenosine monophosphate or methacholine challenge. J Asthma 42:885-890
14. Berman AR, Togias AG, Skloot G, Proud D (1995) Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholine. J Appl Physiol 78:1844-1852
15. Bertolet BD, Belardinelli L, Franco EA, Nichols WW, Kerensky RA, Hill JA (1996) Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans. Circulation 93:1871-1876
16. Beukers MW, Meurs I, Ijzerman AP (2006) Structure-affinity relationships of adenosine A2B receptor ligands. Med Res Rev 26:667-698
17. Bjorck T, Gustafsson LE, Dahlen S-E (1992) Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 145:1087-1091
18. Blackburn MR, Volmer JB, Thrasher JL, Zhong H, Crosby JR, Lee JJ, Kellems RE (2000) Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 192:159-170
19. Blackburn MR, Lee CG, Young HWJ, Zhu Z, Chunn JL, Kang MJ, Banerjee SK, Elias JA (2003) Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 112:332-344
20. Bochenek G, Nizankowska E, Gielicz A, Szczeklik A (2008) Mast cell activation after adenosine inhalation challenge in patients with bronchial asthma. Allergy 63:140-141
21. Bond RA, Spina D, Parra S, Page CP (2007) Getting to the heart of asthma: can "beta blockers" be useful to treat asthma? Pharmacol Ther 115:360-374
22. Bonneau O, Wyss D, Ferretti S, Blaydon C, Stevenson CS, Trifilieff A (2006) Effect of adenosine A2A receptor activation in murine models of respiratory disorders. Am J Physiol Lung Cell Mol Physiol 290:L1036-L1043
23. Breschi MC, Blandizzi C, Fogli S, Martinelli C, Adinolfi B, Calderone V, Camici M, Martinotti E, Nieri P (2007) In vivo adenosine A(2B) receptor desensitization in guinea-pig airway smooth muscle: implications for asthma. Eur J Pharmacol 575:149-157
24. Brown RA, Clarke GW, Ledbetter CL, Hurle MJ, Denyer JC, Simcock DE, Coote JE, Savage TJ, Murdoch RD, Page CP, Spina D, O'Connor BJ (2008) Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Eur Respir J 31:311-319
25. Bshesh K, Zhao B, Spight D, Biaggioni I, Feokistov I, Denenberg A,Wong HR, Shanley TP (2002) The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol 72:1027-1036
26. Bucchioni E, Csoma Z, Allegra L, Chung KF, Barnes PJ, Kharitonov SA (2004) Adenosine 5- monophosphate increases levels of leukotrienes in breath condensate in asthma. Respir Med 98:651-655
27. Busse WW, Lemanske RF Jr (2001) Asthma. N Engl J Med 344:350-362
28. Chuaychoo B, LeeMG, Kollarik M, Pullmann R Jr, Undem BJ (2006) Evidence for both adenosine A1 and A2A receptors activating single vagal sensory C-fibres in guinea pig lungs. J Physiol 575:481-490
29. Chunn JL, Young HW, Banerjee SK, Colasurdo GN, Blackburn MR (2001) Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol 167:4676-4685
30. Clancy JP, Ruiz FE, Sorscher EJ (1999) Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2B receptor-coupled pathway. Am J Physiol 276(2 Pt 1): C361-C369
31. Clark AN, Youkey R, Liu X, Jia L, Blatt R, Day Y-J, Sullivan GW, Linden J, Tucker, AL (2007) A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ Res 101:1-9
32. Cockcroft DW, Davis BE (2006) Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 118:551-559
33. Cohn L, Elias JA, Chupp GL (2004) Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22:789-815
34. Crimi N, Palermo F, Oliveri R,Maccarrone C, Palermo B, Vancheri C, Polosa R,Mistretta A (1988) Enhancing effect of dipyridamole inhalation on adenosine-induced bronchospasm in asthmatic patients. Allergy 43:179-183 (Pubitemid 18120744)
35. Crimi N, Palermo F, Oliveri R, Palermo B, Polosa R, Mistretta A (1992) Protection of nedocromil sodium on bronchoconstriction induced by inhaled neurokinin A (NKA) in asthmatic patients. Clin Exp Allergy 22:75-81
36. Cronstein BN (2006) Adenosine receptors and wound healing, revised. Sci World J 6:984-991
37. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R (1983) Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158:1160-1177
38. Cronstein BN, Daguma L, Nichols D, Hutchison AJ,Williams M (1990) The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 85:1150-1157
39. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB,Weissmann G (1992) Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148:2201-2206
40. Csoma Z, Husźar E, Vizi E, Vass G, Szab́o Z, Herjavecz I, Kollai M, Horv́ath I (2005) Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J 25:873-878
41. Cushley MJ, Tattersfield AE, Holgate ST (1983) Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15:161-165
42. Dahlen S.-E, Hansson G, Hedqvist P, Bjorck T, Granstrom E, Dahlen B (1983) Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Proc Natl Acad Sci USA 80:1712-1716
43. de Meer G, Heederik D, Postma DS (2002) Bronchial responsiveness to adenosine 5- monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV1. Am J Respir Crit Care Med 165:327-331
44. Deussen A (2000) Metabolic flux rates of adenosine in the heart. Naunyn-Schmiedeberg's Arch Pharmacol 362:351-363
45. Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S (2007) The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Failure 13:609-617
46. Doggrell SA (2005) BG-9928 Biogen Idec. Curr Opin Investig Drugs 6: 962-968
47. Driver AG, Kukoly CA, Metzger WJ, Mustafa SJ (1991) Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma. Am Rev Respir Dis 143:1002-1007
48. Driver AG, Kukoly CA, Ali S, Mustafa SJ (1993) Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148:91-97
49. el-Hashim A, D'Agostino B, Matera MG, Page CP (1996) Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits. Br J Pharmacol 119:1262-1268
50. Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC, Colgan SP (2004) Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104:3986-3992
51. Ethier MF,Madison JM (2006) Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells. Am J Respir Cell Mol Biol 35:496-502
52. Ezeamuzie CI (2001) Involvement of A(3) receptors in the potentiation by adenosine of the inhibitory effect of theophylline on human eosinophil degranulation: possible novel mechanism of the anti-inflammatory action of theophylline. Biochem Pharmacol 61:1551-1559
53. Ezeamuzie CI, Philips E (1999) Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol 127:188-194
54. Fan M, Mustafa SJ (2002) Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model. Pul Pharmacol Ther 15:147-155
55. Fan M, Mustafa SJ (2006) Role of adenosine in airway inflammation in an allergic mouse model of asthma. Int Immunopharmacol 6:36-45
56. FanM, QinW, Mustafa SJ (2003) Characterization of adenosine receptor(s) involved in adenosineinduced bronchoconstriction in an allergic mouse model. Am J Physiol Lung Cell Mol Physiol 284:L1012-L1019
57. Feoktistov I, Biaggioni I (1995) Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96:1979-1986
58. Feoktistov I, Goldstein AE, Biaggioni I (1999) Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol 55:726-734
59. Feoktistov I, Garland EM, Goldstein AE, Zeng D, Belardinelli L, Wells JN, Biaggioni I (2001) Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2). Biochem Pharmacol 62:1163-1173
60. Fishman P, Bar-Yehuda S (2003) Pharmacology and therapeutic applications of A3 receptor subtype. Curr Top Med Chem 3:463-469
61. Fozard JR, Ellis KM, Villela Dantas MF, Tigani B, Mazzoni L (2002) Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol 438:183-188
62. Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Diff 14:1315-1323
63. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552
64. Gao Z-G, Jacobson KA (2007) Emerging adenosine receptor agonists. Expert Opin Emerg Drugs 12:479-492
65. Gaspardone A, Crea F, Iamele M, Tomai F, Versaci F, Pellegrino A, Chiariello L, Gioffre PA (1993) Bamiphylline improves exercise-induced myocardial ischemia through a novel mechanism of action. Circulation 88:502-508
66. Gessi S, Merighi S, Varani K, Leung E, Lennan SM, Borea PA (2008) The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 117:123-140
67. Gil FR, Lauzon AM (2007) Smooth muscle molecular mechanics in airway hyperresponsiveness and asthma. Can J Physiol Pharmacol 85:133-140
68. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (2007) The effect of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50:1551-1560
69. Gottlieb SS, Brater C, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT (2002) BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105:1348-1353
70. Greenberg B, Ignatius T, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT (2007) Effects of multiple oral doses of an A1 adenosine receptor antagonist, BG 9928, in patients with heart failure. J Am Coll Cardiol 50:600-606
71. Gunther GR, Herring MB (1991) Inhibition of neutrophil superoxide production by adenosine released from vascular endothelial cells. Ann Vasc Surg 5:325-330
72. Hammad H, Lambrecht BN (2007) Lung dendritic cell migration. Adv Immunol 93:265-278
73. Hannon JP, Tigani B, Wolber C, Williams I, Mazzoni L, Howes C, Fozard JR (2002) Evidence for an atypical receptor mediating the augmented bronchoconstrictor response to adenosine induced by allergen challenge in actively sensitized Brown Norway rats. Br J Pharmacol 135:685-696
74. Hasko G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25:33-39
75. Hasko G, Kuhel DG, Nemeth ZH, Mabley JG, Stachlewitz RF, Virag L, Lohinai Z, Southan GJ, Salzman AL, Szabo C (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164:1013-1019
76. Hasko G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25:152-157
77. Hess S (2001) Recent advances in adenosine receptor antagonist research. Expert Opin Ther Pat 11:1533-1561
78. Holgate ST (2002) Adenosine provocation: a new test for allergic type airway inflammation. Am J Respir Crit Care Med 165:317-319
79. Holgate ST (2007) The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 28:248-251
80. Hong JL, Ho CY, Kwong K, Lee LY (1998) Activation of pulmonary C fibres by adenosine in anaesthetized rats: role of adenosine A1 receptors. J Physiol 508:109-118
81. Hua X, Erikson CJ, Chason KD, Rosebrock CN, Deshpande DA, Penn RB, Tilley SL (2007a) Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice. Am J Physiol Lung Cell Mol Physiol 293:L25-L32
82. Hua X, Kovarova M, Chason KD, Nguyen M, Koller BH, Tilley SL (2007b) Enhanced mast cell activation in mice deficient in the A2b adenosine receptor. J Exp Med 204:117-128
83. Huang P, Lazarowski ER, Tarran R, Milgram SL, Boucher RC, Stutts MJ (2001) Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc Natl Acad Sci USA 98:14120-14125
84. Hyde RJ, Cass CE, Young JD, Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63
85. Ihre E, Gyllfors P, Gustafsson LE, Kumlin M, Dahĺen B (2006) Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge. Eur Respir J 27:1152-1159
86. Jacobsen EA, Ochkur SI, Lee NA, Lee JJ (2007) Eosinophils and asthma. Curr Allergy Asthma Rep 7:18-26
87. Jarjour NN, Kelly EAB (2002) Pathogenesis of asthma. Med Clin North Am 86:925-936
88. Johnson HG, McNee ML (1985) Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives. Br J Pharmacol 86:63-67
89. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271:33116-33122
90. Kalk P, Eggert B, Relle K, Godes M, Heiden S, Sharkovska Y, Fischer Y, Ziegler D, Bielenberg G-W, Hocher B (2007) The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol 151:1025-1032
91. Kallinich T, Beier KC, Wahn U, Stock P, Hamelmann E (2007) T-cell co-stimulatory molecules: their role in allergic immune reactions. Eur Respir J 29:1246-1255
92. Keir S, Boswell-Smith V, Spina D, Page C (2006) Mechanism of adenosine-induced airways obstruction in allergic guinea pigs. Br J Pharmacol 47:720-728
93. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'Connor BJ (2002) Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5--monophosphate in mild asthma. J Allergy Clin Immunol 110:603-606
94. Knight D, Zheng X, Rocchini C, Jacobson M, Bai T, Walker B (1997) Adenosine A3 receptor stimulation inhibits migration of human eosinophils. J Leukoc Biol 62:465-468
95. Langley SJ, Allen DJ, Houghton C, Woodcock A (2005) Efficacy of EPI-2010 (an inhaled respirable anti-sense oligonucleotide: RASON) in moderate/severe persistent asthma. Am J Resp Crit Care Med 171:A360
96. Lappas CM, Sullivan GW, Linden J (2005) Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin Investig Drugs 14:797-806
97. Lee MG, Kollarik M, Chuaychoo B, Undem BJ (2004) Ionotropic and metabotropic receptor mediated airway sensory nerve activation. Pulm Pharmacol Ther 17:355-360
98. Lennon PF, Taylor CT, Stahl GL, Colgan SP (1998) Neutrophil-derived 5--adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 188:1433-1443
99. Liu AMF, Wong YH (2004) G16-mediated activation of nuclear factor ?B by the adenosine A1 receptor involves c-Src, protein kinase C, and ERK signaling. J Biol Chem 279:53196-53204
100. Livingston M, Heaney LG, Ennis M (2004) Adenosine, inflammation, and asthma: a review. Inflamm Res 53:171-178
101. Lloyd CM, Robinson DS (2007) Allergen-induced airway remodelling. Eur Respir J 29:1020-1032
102. Luijk B, van den BergeM, Kerstjens HA, Postma DS, Cass L, Sabin A, Lammers JW (2008) Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response. Allergy 63:75-80
103. Lukashev D, Ohta A, Apasov S, Chen JF, Sitkovsky M (2004) Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J Immunol 173:21-24
104. Ma B, Blackburn MR, Lee CG, Homer RJ, Liu W, Flavell RA, Boyden L, Lifton RP, Sun C-X, Young HW, Elias JA (2006) Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J Clin Invest 116:1274-1283
105. Madara JL, Patapoff TW, Gillece-Castro B, Colgan SP, Parkos CA, Delp C, Mrsny RJ (1993) 5-Adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 91:2320-2325
106. Mann JS, Cushley MJ, Holgate ST (1985) Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis 132:1-6
107. Mann JS, Holgate ST, Renwick AG, Cushley MJ (1986a) Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 61:1667-1676
108. Mann JS, Renwick AG, Holgate ST (1986b) Release of adenosine and its metabolites from activated human leucocytes. Clin Sci 70:461-468
109. Manrique HA, Ǵomez FP, Muñoz PA, Peña AM, Barber̀a JA, Roca J, Rodríguez-Roisin R (2008) Adenosine 5-monophosphate in asthma: gas exchange and sputum cellular responses. Eur Respir J 31:1205-1212
110. Marcus AJ, Safier LB, Broekman MJ, Islam N, Fliessbach JH, Hajjar KA, Kaminski WE, Jendraschak E, Silverstein RL, von Schacky C (1995) Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Thromb Haemost 74: 213-217
111. McNamara N, Gallup M, Khong A, Sucher A, Maltseva I, Fahy J, Basbaum C (2004) Adenosine up-regulation of the mucin gene, MUC2, in asthma. FASEB J 18:1770-1772
112. Mohsenin A, Mi T, Xia Y, Kellems RE, Chen JF, Blackburn MR (2007) Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. Am J Physiol Lung Cell Mol Physiol 293:L753-L761
113. Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J, LiM, Jiang C-K, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN (1997)Wound healing is accelerated by agonists of adenosine A2 (Gs-linked) receptors. J Exp Med 186:1615-1620
114. Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN (2006) Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 164:1887-1892
115. Moro S, Gao Z-G, Jacobson KA, Spalluto G (2006) Progress in the pursuit of therapeutic adenosine receptor antagonists. Med Res Rev 26:131-159
116. Mustafa SJ, Nadeem A, Fan M, Zhong H, Belardinelli L, Zeng D (2007) Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 320:1246-1251
117. Nadeem A, Obiefuna PC,Wilson CN, Mustafa SJ (2006) Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation. Eur J Pharmacol 551:116-124
118. Nadeem A, Fan M, Ansari HR, Ledent C, Jamal Mustafa S (2007) Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice. Am J Physiol Lung Cell Mol Physiol 292:L1335-L1344
119. Nadeem A, Ponnoth DS, Batchelor T, Dey RD, Ledent C, Mustafa SJ (2008) Decreased tracheal relaxation via NADPH oxidase activation in A2A AR deficent allergic mice. Am J Respir Crit Care Med 177:A487
120. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundstrom C, Nilsson K, Hellman L (1994) Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 39:489-498
121. Nyce JW, Metzger WJ (1997) DNA antisense therapy for asthma in an animal model. Nature 385:721-725
122. Obiefuna PC, Batra VK, Nadeem A, Borron P, Wilson CN, Mustafa SJ (2005) A novel A1 adenosine receptor antagonist, L-97-1 [3-[2-(4-aminophenyl)-ethyl]-8- benzyl-7-{2-ethyl- (2-hydroxy-ethyl)-amino]-ethyl}-1-propyl-3,7-dihydro-purine- 2,6-dione], reduces allergic responses to house dust mite in an allergic rabbit model of asthma. J Pharmacol Exp Ther 315:329-336
123. O'Connor BJ, Crowther SD, Costello JF, Morley J (1999) Selective airway responsiveness in asthma. Trends Pharmacol Sci 20:9-11
124. Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P, Chen JF, Jackson EK, Apasov S, Abrams S, Sitkovsky M (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 103:13132-13137
125. Oldenburg PJ, Mustafa SJ (2005) Involvement of mast cells in adenosine-mediated bronchoconstriction and inflammation in an allergic mouse model. J Pharmacol Exp Ther 313:319-324
126. Panther E, Idzko M, Herouy Y, Rheinen H, Gebicke-Haerter PJ, Mrowietz U, Dichmann S, Norgauer J (2001) Expression and function of adenosine receptors in human dendritic cells. FASEB J 15:1963-1970
127. Pascoe SJ, Knight H, Woessner R (2007) QAF805, an A2b/A3 adenosine receptor antagonist does not attenuate AMP challenge in subjects with asthma. Am J Respir Crit Care Med 175:A682
128. Pastor-Anglada M, Casado FJ, Valdes R, Mata J, Garcia-Manteiga J, Molina M (2001) Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol 18:81-85
129. Phillips GD, Holgate ST (1989) The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5-monophosphate in nonatopic asthma. Am Rev Respir Dis 139:463-469
130. Polosa R (2002) Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructed pulmonary disease. Eur Respir J 20:488-496
131. Polosa R, Phillips GD, Rajakulasingam K, Holgate ST (1991) The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5--monophosphate and histamine in asthma. J Allergy Clin Immunol 87:939-947
132. Polosa R, Ng WH, Crimi N, Vancheri C, Holgate ST, Church MK, Mistretta A (1995) Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 151:624-629
133. Polosa R, Renaud L, Cacciola R, Prosperini G, Crimi N, Djukanovic R (1998) Sputum eosinophilia is more closely associated with airway responsiveness to bradykinin than methacholine in asthma. Eur Respir J 12:551-556
134. Press NJ, Taylor RJ, Fullerton JD, Tranter P, McCarthy C, Keller TH, Brown L, Cheung R, Christie J, Haberthuer S, Hatto JD, Keenan M, Mercer MK, Press NE, Sahri H, Tuffnell AR, Tweed M, Fozard JR (2005) A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential. Bioorg Med Chem Lett 15:3081-3085
135. Ramkumar V, Stiles GL, Beaven MA, Ali H (1993) The A3 adenosine receptor is the unique adenosine receptor, which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890
136. Reeves JJ, Harris CA, Hayes BP, Butchers PR, Sheehan MJ (2000) Studies on the effects of adenosine A3 receptor stimulation on human eosinophils isolated from non-asthmatic or asthmatic donors. Inflamm Res 49:666-672
137. Resta R, Yamashita Y, Thompson LF (1998) Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 161:95-109
138. Reynolds CJ, Togias A, Proud D (2002) Airways hyper-responsiveness to bradykinin and methacholine: effects of inhaled fluticasone. Clin Exp Allergy 32:1174-1179
139. Reynolds SM, Docherty R, Robbins J, Spina D, Page CP (2008) Adenosine induces a cholinergic tracheal reflex contraction in guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism. J Appl Physiol 105:187-196
140. Rimmer J, Peake HL, Santos CM, Lean M, Bardin P, Robson R, Haumann B, Loehrer F, Handel ML (2007) Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 37:8-14
141. Roisman GL, Lacronique JG, Desmazes DN, Carre C, Le-Cae A, Dusser DJ (1996) Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am J Respir Crit Care Med 153:381-390
142. Roman J, Rivera HN, Roser-Page S, Sitaraman SV, Ritzenthaler JD (2006) Adenosine induces fibronectin expression in lung epithelial cells: implications for airway remodeling. Am J Physiol Lung Cell Mol Physiol 290:L317-L325
143. Rorke S, Holgate ST (2002) Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease. Am J Respir Med 1:99-105 (Pubitemid 37038928)
144. Rorke S, Jennison S, Jeffs JA, Sampson AP, Holgate ST (2002) Role of cysteinyl leukotrienes in adenosine 5-monophosphate induced bronchoconstriction in asthma. Thorax 57:323-327
145. Rosenberg HF, Phipps S, Foster PS (2007) Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 119:1303-1310
146. Rounds S, Hsieh L, Agarwal KC (1994) Effects of endotoxin injury on endothelial cell adenosine metabolism. J Lab Clin Med 123:309-317
147. Rutgers SR, Koeter GH, Van Der Mark TW, Postma DS (1999) Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5-monophosphate-induced bronchoconstriction in patients with COPD. Clin Exp Allergy 29:1287-1292
148. Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, Feoktistov I (2004) Adenosineactivated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 172: 7726-7733
149. Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Dikov MM, Blackburn MR, Biaggioni I, Feoktistov I (2008a) Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. J Immunol 180:7212-7220
150. Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Blackburn MR, Biaggioni I, Feoktistov I (2008b) Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J Pharmacol Exp Ther 324:694-700
151. Salmon JE and Cronstein BN (1990) Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory. J Immunol 145: 2235-2240
152. Salmon JE, Brogle N, Brownlie C, Edberg JC, Kimberly RP, Chen BX, Erlanger BF (1993) Human mononuclear phagocytes express adenosine A1 receptors. A novel mechanism for differential regulation of Fc gamma receptor function. J Immunol 151:2775-2785
153. Salpeter SR, Ormiston TM, Salpeter EE (2004) Cardiovascular effects of beta-agonists in patients with asthma and COPD: a metanalysis. Chest 125:2309-2321
154. Slats AM, Janssen K, van SA, van der Plas DT, Schot R, van den Aardweg JG, de Jongste JC, Hiemstra PS, Mauad T, Rabe KF, Sterk PJ (2007) Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:121-128
155. Sont JK, Booms P, Bel EH, Vandenbroucke JP, Sterk PJ (1993) The determinants of airway hyperresponsiveness to hypertonic saline in atopic asthma in vivo. Relationship with sub-populations of peripheral blood leucocytes. Clin Exp Allergy 23:678-688
156. Sperlagh B, Hasko G, Nemeth Z, Vizi ES (1998) ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int 33: 209-215
157. Spicuzza L, Bonfiglio C, Polosa R (2003) Research applications and implications of adenosine in diseased airways. Trends Pharmacol Sci 24:409-413
158. Spicuzza L, Di Maria G, Polosa R (2006) Adenosine in the airways: implications and applications. Eur J Pharmacol 533:77-88
159. Spina D, Page CP (1996) Airway sensory nerves in asthma: targets for therapy? Pulm Pharmacol 9:1-18 (Pubitemid 26253956)
160. Spina D, Page CP (2002) Pharmacology of airway irritability. Curr Opin Pharmacol 2:264-272
161. Spruntulis LM, Broadley KJ (2001) A3 receptors mediate rapid inflammatory cell influx into the lungs of sensitized guinea-pigs. Clin Exp Allergy 31:943-951
162. Sullivan GW (2003) Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Investig Drugs 4:1313-1319
163. Sun CX, Young HW, Molina JG, Volmer JB, Schnermann J, Blackburn MR (2005) A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 115:35-43
164. Sun CX, Zhong H, Mohsenin A, Morschl E, Chunn JL, Molina JG, Belardinelli L, Zeng D, Blackburn MR (2006) Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 116:2173-2182
165. ThielM, Caldwell CC, SitkovskyMV (2003) The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microb Infect 5:515-526
166. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, Colgan SP (2004) Crucial role for ecto-5--nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200:1395-1405
167. Tilley SL, Tsai M, Williams CM, Wang ZS, Erikson CJ, Galli SJ, Koller BH (2003) Identification of A3 receptor- and mast cell-dependent and -independent components of adenosine-mediated airway responsiveness in mice. J Immunol 171:331-337
168. van den Berge M, Kerstjens HA, Meijer RJ, de Reus DM, Koeter GH, Kauffman HF, Postma DS (2001) Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 164:1127-1132 (Pubitemid 33052238)
169. van den BergeM, Kerstjens HA, de Reus DM, Koeter GH, Kauffman HF, Postma DS (2004) Provocation with adenosine 5--monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy 34:71-76
170. Van Schoor J, Joos GF, Pauwels RA (2000) Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J 16:514-533
171. Van Schoor J, Joos GF, Pauwels RA (2002) Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma. Eur Respir J 19:997-1002
172. van Troostenburg A-R, Clark EV, Carey WDH, Warrington SJ, Kerns WD, Cohn I, Silverman MH, Bar-Yehuda S, Fong K-LL, Fishman P (2004) Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF 101, an A3 adenosine receptor agonist, in healthy young men. Internat J Clin Pharmacol Ther 42:534-542
173. Visser SS, Theron AJ, Ramafi G, Ker JA, Anderson R (2000) Apparent involvement of the A2A subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils. Biochem Pharmacol 60:993-999
174. Vizi E, Huzzar E, Csoma Z, Boszormenyi-Nagy G, Barat E, Horvath I, Herjavecz I, Kollai M (2002) Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol 109:446-448
175. Walker BAM, Jacobson MA, Knight DA, Salvatore CA,Weir T, Zhou D, Bai TR (1997) Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 16:531-537
176. Webb RL, SillsMA, Chovan JP, Peppard JV, Francis JE (1993) Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration. J Pharmacol Exp Ther 267:287-295
177. Wilson CN, Batra VK (2002) Lipopolysaccharide binds to and activates A(1) adenosine receptors on human pulmonary artery endothelial cells. J Endotoxin Res 8:263-271
178. Wilson CN (2008) Adenosine receptors and asthma in humans. Br J Pharmacol 155:475-486
179. Xiang Z, Ahmed AA, Moller C, Nakayama K, Hatakeyama S, Nilsson G (2001) Essential role of the prosurvival bcl-2 homologue A1 in the mast cell survival after allergic activation. J Exp Med 194:1561-1569
180. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, Hilaire CS, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K (2006) The A(2B) adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116:1913-1923
181. Yang D, Koupenova M, McCrann DJ, Kopeikina KJ, Kagan HM, Schreiber BM, Ravid K (2008) The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci USA 105: 792-796
182. Young HW, Molina JG, Dimina D, Zhong H, Jacobson M, Chan LN, Chan TS, Lee JJ, Blackburn MR (2004) A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173:1380-1389
183. Young HW, Sun CX, Evans CM, Dickey BF, Blackburn MR (2006) A3 adenosine receptor signaling contributes to airway mucin secretion after allergen challenge. Am J Respir Cell Mol Biol 35:549-558
184. Yuzlenko O, Kiec-Kononowicz K (2006) Potent adenosine A1 and A2A receptor antagonists: recent developments. Curr Med Chem 13:3609-3625
185. Zhong H, Shlykov SG, Molina JG, Sanborn BM, Jacobson MA, Tilley SL, Blackburn MR (2003) Activation of murine lung mast cells by the adenosine A3 receptor. J Immunol 171:338-345
186. Zhong H, Belardinelli L, Maa T, Feoktistov I, Biaggioni I, Zeng D (2004) A2B adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol 30: 118-125
187. Zhong H, Belardinelli L, Maa T, Zeng D (2005) Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts. Am J Respir Cell Mol Biol 32:2-8
188. Zhong H, Wu Y, Belardinelli L, Zeng D (2006) A2B adenosine receptors induce IL-19 from bronchial epithelial cells and results in TNF-alpha increase. Am J Respir Cell Mol Biol 35: 587-592
189. Zimmermann H (1999) Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis. Nat Med 5:987-988